Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan
Clinical trial NCT01835470 · COMPLETED
Trial details
- NCT number
- NCT01835470
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-09
- Primary completion
- 2015-11-24
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.